Previous pharmacologic and genetic studies have demonstrated a critical role for the low molecular weight GTP-binding protein RhoA in the regulation of cell-mediated killing by cytotoxic lymphocytes. However, a specific Rho family guanine nucleotide exchange factor (GEF) that activates this critical regulator of cellular cytotoxicity has not been identified. In this study, we provide evidence that the Rho family GEF, Vav-2, is present in cytotoxic lymphocytes, and becomes tyrosine phosphorylated after the cross-linking of activating receptors on cytotoxic lymphocytes and during the generation of cell-mediated killing. In addition, we show that overexpression of Vav-2 in cytotoxic lymphocytes enhances cellular cytotoxicity, and this enhancement requires a functional Dbl homology and Src homology 2 domain. Interestingly, the pleckstrin homology domain of Vav-2 was found to be required for enhancement of killing through some, but not all activating receptors on cytotoxic lymphocytes. Lastly, although Vav and Vav-2 share significant structural homology, only Vav is able to enhance nuclear factor of activated T cells–activator protein 1–mediated gene transcription downstream of the T cell receptor. These data demonstrate that Vav-2, a Rho family GEF, differs from Vav in the control of certain lymphocyte functions and participates in the control of cell-mediated killing by cytotoxic lymphocytes.
Skip Nav Destination
Article navigation
7 August 2000
Article|
August 08 2000
The Rho Family Guanine Nucleotide Exchange Factor Vav-2 Regulates the Development of Cell-Mediated Cytotoxicity
Daniel D. Billadeau,
Daniel D. Billadeau
aDepartment of Immunology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, Minnesota 55905
Search for other works by this author on:
Stacy M. Mackie,
Stacy M. Mackie
aDepartment of Immunology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, Minnesota 55905
Search for other works by this author on:
Renee A. Schoon,
Renee A. Schoon
aDepartment of Immunology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, Minnesota 55905
Search for other works by this author on:
Paul J. Leibson
Paul J. Leibson
aDepartment of Immunology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, Minnesota 55905
Search for other works by this author on:
Daniel D. Billadeau
aDepartment of Immunology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, Minnesota 55905
Stacy M. Mackie
aDepartment of Immunology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, Minnesota 55905
Renee A. Schoon
aDepartment of Immunology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, Minnesota 55905
Paul J. Leibson
aDepartment of Immunology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, Minnesota 55905
Abbreviations used in this paper: ADCC, antibody-dependent cellular cytotoxicity; AP, activator protein; CH, calponin homology; DH, Dbl homology; GEFs, guanine nucleotide exchange factors; NFAT, nuclear factor of activated T cells; NRS, normal rabbit serum; PH, pleckstrin homology; PI3-K, phosphatidyl inositol 3-kinase; PR, proline-rich region; PTKs, protein tyrosine kinases; SH, Src homology; WR, wild-type vaccinia virus.
Received:
March 23 2000
Revision Requested:
May 19 2000
Accepted:
May 23 2000
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 192 (3): 381–392.
Article history
Received:
March 23 2000
Revision Requested:
May 19 2000
Accepted:
May 23 2000
Citation
Daniel D. Billadeau, Stacy M. Mackie, Renee A. Schoon, Paul J. Leibson; The Rho Family Guanine Nucleotide Exchange Factor Vav-2 Regulates the Development of Cell-Mediated Cytotoxicity. J Exp Med 7 August 2000; 192 (3): 381–392. doi: https://doi.org/10.1084/jem.192.3.381
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement